FTO (Freedom to Operate) in the Pharmaceutical Industry /

1st ed.

Book

63 pages

9783845294018

FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed.

This resource was extracted from the Directory of Open Access Books (DOAB)

[Baden-Baden, Germany] : Nomos, 2018.

English

CC-BY-NC-ND